Friday, 16 October 2026European Markets

INAPA-INV.P.GESTAO Stock Went Down By Over 23% In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of INAPA-INV.P.GESTAO (PSI: INA.LS) slid by a staggering 23.66% in 10 sessions from €0.07 to €0.05 at 16:26 EST on Friday, after five sequential sessions in a row of losses. PSI is rising 0.46% to €6,029.18, after two sequential sessions in a row of gains.

About INAPA-INV.P.GESTAO

Inapa - Investimentos, Participações e Gestão, S.A., through its subsidiaries, distributes and sells paper products in Portugal. It operates through three segments: Paper Supply, Packaging, and Visual Communication. The company offers coated, uncoated, carbonless, self-adhesive, stock, board, envelopes, and fine papers; graphics consumables, such as inks, cleaning products, additives printing blankets, plates, and varnishes; office papers; and office supplies. It also provides boxes, films, tapes, fillers, bags, labels, fillings, and equipment, as well as customized solutions and personalized packaging. In addition, the company offers printing products and services for a large format of digital printing, including printers, inks/toners, media, software, and technical assistance, as well as logistic services. Inapa - Investimentos, Participações e Gestão, S.A. was founded in 1965 and is headquartered in Lisbon, Portugal.

Earnings Per Share

As for profitability, INAPA-INV.P.GESTAO has a trailing twelve months EPS of €-0.024.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INAPA-INV.P.GESTAO's stock is considered to be overbought (>=80).

Volatility

INAPA-INV.P.GESTAO's last week, last month's, and last quarter's current intraday variation average was a negative 3.26%, a positive 1.70%, and a positive 4.21%.

INAPA-INV.P.GESTAO's highest amplitude of average volatility was 3.26% (last week), 5.39% (last month), and 4.21% (last quarter).

Volume

Today's last reported volume for INAPA-INV.P.GESTAO is 1741718 which is 56.4% below its average volume of 1409470.

More news about INAPA-INV.P.GESTAO (INA.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com